Physician profile
Macorazon E Yuzon
NPI 1679683817
$1,170.36
in general payments reported to CMS, 2019-2025
15 companies · $314 in 2025
The $314 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.85 · 2020: $147 · 2021: $139 · 2022: $191 · 2023: $235 · 2024: $79.55 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $361.04 | 2019-2025 | Bexsero, Penmenvy |
| Dexcom, INC. | $140.86 | 2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $139.98 | 2025 | |
| Verrica Pharmaceuticals INC. | $126.14 | 2025 | Ycanth |
| Abbvie INC. | $106.35 | 2020 | |
| Acadia Pharmaceuticals INC | $79.55 | 2024 | Daybue |
| Cranial Technologies, INC | $49.11 | 2021-2023 | Doc Band |
| Sanofi Pasteur INC. | $32.71 | 2023 | |
| Exact Sciences Corporation | $31.31 | 2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $22.93 | 2023 | Twirla |
| Sobi, INC | $20.30 | 2022 | |
| Novo Nordisk INC | $18.97 | 2023 | Wegovy |
| Pfizer INC. | $16.98 | 2020 | |
| Phadia US INC. | $12.89 | 2020 | |
| Lilly USA, LLC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macorazon Yuzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.